Delcath Gets FDA Approval for Cancer Drug-Device Combo 10 Years After Rejection

The FDA on Monday approved Delcath Systems’ Hepzato Kit for the liver-directed treatment of adult patients with metastatic uveal melanoma, capping a nearly decade-long effort to secure regulatory approval.